baber/WOPTO huggingface dataset:
Patent IL-104886-A0 (IL)
Title: Adenine derivatives and pharmaceutical compositions containing the same
IPC: C07H21/00
Filed: 1993-02-28
Abstract: Viral infection is inhibited in mammals by administration of metabolically stable, non-toxic 2',5'-oligoadenylate (2-5A) derivatives that have a dual therapeutic effect. The compounds activate the intracellular latent 2-5A dependent endoribonuclease RNase L and also inhibit the action of viral DNA polymerases. Conjugates of the 2-5A derivatives for therapeutic delivery are also described.
Patent IL-112539-A0 (IL)
Title: Pyrimidine derivatives and their preparation
IPC: C07D405/12
Filed: 1995-02-03
Abstract: The present invention relates to certain novel pyrimidine intermediates and their salts, processes for their preparation and processes for their conversion to 9-substituted-2-aminopurines which are useful in medical therapy.
Patent IL-113794-A0 (IL)
Title: Formulations for nebulisation administration and their use
IPC: A61K9/72
Filed: 1995-05-19
Abstract: PCT No. PCT/EP95/01913 Sec. 371 Date Feb. 7, 1997 Sec. 102(e) Date Feb. 7, 1997 PCT Filed May 19, 1995 PCT Pub. No. WO95/31964 PCT Pub. Date Nov. 30, 1995Suspension formulations suitable for nebulization, for administration by inhalation, comprising fluticasone propionate with a particle size less than 12 microns, one or more surfactants, one or more buffer agents and water. Also described are a method of preparing such a formulation, a container comprising the formulation, and a method of treating asthma using the formulation.
Patent IL-119400-A0 (IL)
Title: Process for the preparation of enantiomerically pure imidazolyl compounds
IPC: A61K31/435
Filed: 1996-10-10
Abstract: The invention relates to a method for the preparation of an enantiomerically pure imidazolyl compound of the general formula <CHEM>  wherein:     n is 0 or 1;   m is 1 or 2;   R1 is hydrogen, methyl or ethyl; and   C* denotes a chiral centre;  as well as its pharmaceutically acceptable acid addition salt; by   a) adding a carboxylic acid in an optically active form to a solution of a racemic mixture of the above compound I, followed by separation of the crystallized acid addition salt of said mixture of enantiomers of compound I enriched in one enantiomer, from the mother liquor enriched in the other enantiomer b) when the crystallized acid addition salt is enriched in the undesired enantiomer, by then separating the mixture of enantiomers in the mother liquor from said optically active carboxylic acid, followed by addition of a racemic mixture of said carboxylic acid to a solution of the obtained mixture of isomers of I, and by separation of the crystallized acid addition salt of said mixture, enriched in the desired enantiomer, from the mother liquor, and (c) optionally recrystallizing the product until the desired enantiomeric purity is obtained, and by then (d) converting this acid-addition salt of the desired enantiomer to the desired enantiomerically pure imidazolyl compound of the general formula I or to its pharmaceutically acceptable acid addition salt, characterized in that pyroglutamic acid is used as said carboxylic acid. The invention further relates to a method of racemisation and to a new acid addition salt of this formula I compound and D-pyroglutamic acid.
Patent IL-124353-A0 (IL)
Title: Production of a salt of clavulanic acid
IPC: A61K31/431
Filed: 1996-11-14
Abstract: PCT No. PCT/EP96/05015 Sec. 371 Date May 11, 1998 Sec. 102(e) Date May 11, 1998 PCT Filed Nov. 14, 1996 PCT Pub. No. WO97/18216 PCT Pub. Date May 22, 1997Process for the production of alkali salts of clavulanic acid of formula by conversion of clavulanic acid into a pharmaceutically acceptable salt of clavulanic acid which is characterised in that the conversion is carried out in n-butanol or iso-butanol (2-methyl-1-propanol) as a solvent; and a potassium salt of clavulanic acid containing n-butanol or iso-butanol.
Patent IL-133566-A0 (IL)
Title: Compounds derived from thiophene and benzothiophene, and related utilisation and composition
IPC: C07D333/22
Filed: 1998-07-01
Abstract: The compounds are of the general formula (I): <CHEM> where Z is: -CO-, -CH(OR6)-, -C(NOR7)-; R1 is: H, C1-C6 alkyl, halogen, or - OR12; R2 and R3 are: H, alkyl, halogen, nitro or -OR12, or R2 and R3 together are -C(R8) = C(R9)- C(R10) = C(R11)-; R4 and R5 are: H, alkyl, halogen, haloalkyl, -OR12, nitro, NR13R14; -COR12; CO2R12; -SO2NR13R14; -SO2R12; SR12, cyano; -CONR13R14 or R4 and R5 form a benzene ring; R6 is: H, alkyl, CO2R12, -C(O)NR13R14, naphthyl or phenyl; R7 is: H or alkyl; R8, R9, R10 and R11 are H, alkyl halogen, OR12, nitro, cyano, NR13R14, -COR12, CO2R12; - SO2NR13R14; -SO2R12; SR12, -CONR13R14; R12 is H, C1-C6 alkyl or phenyl; and R13 and R14 are H, alkyl or phenyl or R13 and R14 form a 5- or 6-membered ring. These compounds are effective for the treatment of anxiety or depression.
Patent IL-139302-A0 (IL)
Title: Antenatal screening for down's syndrome
IPC: G01N33/68
Filed: 1999-04-29
Abstract: A method of screening for fetal Down's syndrome is described. Screening marker levels are measured. These may be measurements of a biochemical marker in a maternal sample or measurements of a marker from an ultrasound scan. The marker levels are used to calculate a risk of Down's syndrome. Instead of using markers from a single stage of pregnancy, the method uses markers from two or more different stages of pregnancy, typically one being in the first and another being in second trimester. The method may be automated.
Patent IL-141328-A0 (IL)
Title: Pantoprazole magnesium dihydrat
IPC: A61K31/4439
Filed: 1999-08-12
Abstract: The invention relates to the dihydrate of the magnesium salt of pantoprazole.
Patent IL-143590-A0 (IL)
Title: Secure system using continuously-changing features of a body part as a key
IPC: G09C1/00
Filed: 1999-12-08
Abstract: A secure system using a continuously-changing key that depends on the user's body part. A preferred embodiment obtains an image of the user's fingerprint and cements it according to a random generator. Only part of the image and not all of the image is sent at one time. The random segmentation insures that part of the image that is sent continuously varies from time to time. Therefore, an unauthorized receiver can receive only part but not all of the image. That only part of the image which is received will usually not be the same at the second as it is at the first time. Therefore, a received code cannot later be used to fool the system with the same credit card.
Patent IL-146613-A0 (IL)
Title: Method and system for delivery of a secure document
IPC: G06K17/00
Filed: 2000-05-24
Abstract: A system for capturing an electronic message is disclosed. The system includes a printer, a sensing device and a computer system. The printer prints on a substrate user information visible to a user and coded tags invisible to the user. Each coded tag encodes an identity unique to the substrate and a location of the coded tag on the substrate. The user information defines a message area on the substrate. The sensing device senses the coded tags on the substrate when the sensing device is moved relative to the substrate. The computer system electronically captures a message composed with the sensing device via movement of the sensing device relative to the message area, the computer system using the identity of the substrate and a sequence of respective locations of coded tags sensed by the sensing device for determining the movement relative to the message area and the message.
Patent IL-147903-A0 (IL)
Title: Extensible computing system
IPC: H04L29/08
Filed: 2000-08-17
Abstract: Methods and apparatus providing a dynamically sized, highly scalable and available server farm are disclosed. A Virtual Server Farm (VSF) is created out of a wide scale computing fabric ("Computing Grid") which is physically constructed once and then logically divided up into VSFs for various organizations on demand. Each organization retains independent administrative control of a VSF. A VSF is dynamically firewalled within the Computing Grid. Allocation and control of the elements and topology in the VSF is performed by a Control Plane connected to all computing, networking, and storage elements in the computing grid through special control ports. No physical rewiring is necessary in order to construct VSFs in many different configurations, including single-tier Web server or multi-tier Web-server, application server, database server configurations.
Patent IL-156205-A0 (IL)
Title: Rotatable drum inkjet printing apparatus for radiation curable ink
IPC: B41J11/00
Filed: 2001-12-20
Abstract: Inkjet printing apparatus includes a drum, a print head for directing radiation curable ink toward a substrate on the drum, and a curing device for directing radiation toward the ink that is received on the substrate. The curing device is selectively operable to direct radiation toward a certain portion of the ink received on the substrate only after that certain portion has moved with the substrate and the drum through an arc that is at least 360 degrees. In this manner, the ink on the substrate has sufficient time to spread and level and the resultant image is of high quality.
Patent IL-173406-A0 (IL)
Title: A process and apparatus for removing a solvent from a solution
IPC: B01D61/00
Filed: 2006-01-29
Abstract: A process for removing a solvent from a first solution, said process comprising positioning a selective membrane between the first solution and a second solution having a higher osmotic potential than the first solution, such that solvent from the first solution passes across the membrane to dilute the second solution, and extracting solvent from the second solution, wherein the membrane has an average pore size of at least 10 Angstroms, and wherein the second solution contains solute species that are too large to pass through the pores of the membrane.
Patent IL-184665-A0 (IL)
Title: An improved lidded container adapted to withstand internal pressure build-up
Filed: 2007-07-17
Abstract: A lidded container includes a container having an open top defined by an annular rim (113); and a lid (120) having a central section (121) and an outer rim attachable to the rim of the container. The annular rim of the lid includes an annular clamping section defined by spaced inner and outer walls (124,125) for receiving the rim of the container in the space between the walls. The annular clamping section of the lid is integrally joined to the central section (121) of the lid by an annular, elastically deformable juncture section (123) effective to increase the clamping action of the lid clamping section with an increase in pressure within the container.
Patent IL-185138-A0 (IL)
Title: Method and system for detecting, classifying and identifying particles
Filed: 2007-08-09
Abstract: A method and apparatus is disclosed for detecting, classifying and identifying airborne and non-airborne particles on an individual basis in substantially real time by directing a particle stream to react with optical reporters and markers and then exposing the stream to an excitation source such that individual particles have their multiple identifying characteristics detected.
Patent AP-2002002453-A0 (AP)
Title: Chemosensitizer
Inventor: KHAMAR BAKULESH MAFATLAL
IPC: A61K31/4525
Filed: 2001-06-26
Abstract: Chemothearapeutic agents are used to treat infections caused by bacteria, virus,protozoa, parasites, and various malignant disease like cancer. The major problem associated with use of chemotherapeutic agents is resistance to chemoptherapeutic agents. Mechanisms underlying resistance to chemotherapeutic agents include inactivation/modification of antibiotic (beta-lactams,chloramphenicol), insensitive target site (beta-lactams, glycopeptides, macrolides, tetracyclines), decreased drug acculation in the form of enhanced effux (tetracycyclines, chloroquine, macrolides, anticancer drugs), by-pass of antibiotic sensitive step (methi-cillin, sulphonamides)etc. The common mechanisms underlying drug resistance is to restrict concentration of drug at the site of action ussually intracellular. Ths can be in the form or restricting the entry of the drug into the cell by various mechanisms including altered cell wall permeability. It can also be in the form of removing the drug from site of action e.G intracellular so that therapetic concetration are not achieved. The drugs restoring sensitivity of chemotherapeutic agents are broadly known as chemosensitizers.COmpounds belonging to a group of r-1-3benzodiaxole are to be found to be chemosensitizer as per the present inventio. Piperine is one such compound belonging to a group of r-1-3-benzodiaxole are found to be chemosensitizer as per the present invention. Piperine is one such compound belonging to r-1-3 bezodiaxole group. It is found to reverse resistance to chemotherapeutic agents like rifampicin at dose which is easily achievable after oral ingestion of the drug.
Patent MA-19129-A1 (MA)
Inventor: P BLANQUET
IPC: B01J39/12
Filed: 1981-04-21
Abstract: A water insoluble ion exchange resin having a crosslinked, three dimensional resin skeleton and an active group of the formula: <IMAGE>   wherein R is selected from the group consisting of hydrogen and an alkyl radical having 1-15 carbon atoms and having at most two branchings in the alkyl group, and A is a mono-, di-, or tri-substituted ethylene radical or mono- or di-substituted methylene radical, wherein the substituents are selected from the group consisting of an alkyl group having at most two branchings, hydroxy, an amino group and hydrogen and wherein A provides a link binding the active group to the resin skeleton.
Patent MA-20150060-A1 (MA)
Title: Systèmes et procédés de formation de cellules solaires avec des films cuinse2 et cu(in,ga)se
Inventor: ALBIN DAVID S
IPC: H01L31/0272
Filed: 2013-02-27
Abstract: Des systèmes et des procédés permettant de former des cellules solaires à base de films cuinse2 et cu(in,ga)se2 sont décrits par la présente invention. Dans un mode de réalisation, un procédé comprend les étapes suivantes : au cours d'une première étape (220), la réalisation d'un transport de masse par l'intermédiaire d'un transport de vapeur de chlorure d'indium (inclx) en phase vapeur (143, 223) et de vapeur de se (121, 225) pour déposer un film semi-conducteur (212, 232, 252) sur un substrat (114, 210, 230, 250) ; le chauffage du substrat (114, 210, 230, 250) et du film semi-conducteur à une température souhaitée (112) ; au cours d'une deuxième étape (240) suivant la première étape (220), la réalisation d'un transport de masse par l'intermédiaire d'un transport de vapeur de chlorure de cuivre (cuclx) en phase vapeur (143, 243) et de vapeur de se (121, 245) au film de semi-conducteur (212, 232, 252) ; et au cours d'une troisième étape (260) suivant la deuxième étape (240), la réalisation d'un transport de masse par l'intermédiaire d'un transport de vapeur de chlorure d'indium (inclx) en phase vapeur (143, 223) et de vapeur de se (121, 265) au film de semi-conducteur (212, 232, 252).
Patent MA-38075-A1 (MA)
Title: Antagonistes des récepteurs de l'orexine, qui sont des dérivés [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone
Inventor: BOLLI MARTIN
IPC: C07D419/14
Filed: 2013-10-09
Abstract: La présente invention concerne des dérivés [ortho bi-(hétéro-)aryl]-[2-(méta bi-(hétéro-)aryl)-pyrrolidin-1-yl]- méthanone de la formule (i) dans laquelle r, et les cycles a1a2 et a3 sont tels que définis dans la description, leurs sels pharmaceutiquement acceptables, leur préparation, des compositions pharmaceutiques contenant au moins un composé de la formule (i), et leur utilisation comme médicaments, en particulier comme antagonistes des récepteurs de l'oréxine.
Patent UY-24568-A1 (UY)
Title: Metodo para fabricar cubiertas para manos con una almohadilla adjunta
Inventor: MOORE BARRET H
IPC: B29C41/20
Filed: 1997-05-26
Abstract: Un método para fabricar un cobertor para manos con una almohadilla adherida a él donde la almohadilla se coloca en una cavidad de un molde y un material precursor, como por ejemplo látex líquido, que se aplica luego al molde y a la almohadilla. El material precursor se cura entonces para formar el cobertor para manos, que se recorta del molde y se da vuelta para su uso con la almohadilla ligada a él.
Patent UY-26296-A1 (UY)
Title: Tratamiento medicamentoso del síndrome de piernas inquietas
Inventor: BRECHT DR HANS-MICHAEL
IPC: A61K31/485
Filed: 2000-08-16
Abstract: El invento se refiere a una nueva combinación de sutancias activas para el tratamiento más eficaz del síndrome de piernas inquietas (RLS), que consta de un agente agonista alfa 2 y de otro neuro-psicofármaco que reduce los síntomas del RLS como una monoterapia.
Patent UY-28600-A1 (UY)
Title: Composiciones que incluyen ciclohexilaminas y aminoadamantanos
Inventor: GOEL ANSHU
Filed: 2004-11-04
Abstract: La invención está dirigida a composiciones de compuestos farmacéuticso, por ejemplo, a las Ciclohexilaminas y Aminoadamantanos que tienen porpiedades antimicrobianas. En particular, la invención está dirigida a composiciones de base acuosa que contienen cantidades reducidas de preservativos, loque permite su administración segura y conveniente y una dosificación flexible y que, en el caso de las composiciones de uso oral, las hace fáciles de tragar. Las composiciones opcionalmente contienen componentes que proporcionan la estabilidad y la vida útil en almacenamiento requeridas, al mismo tiempo que reducen o impiden la incrustación de la composición alrededor de la tapa del recipiente, lo que tiene como resultado filtraciones y dificultad para abrirlo.
Patent UY-28728-A1 (UY)
Title: Metodo de produccion de agregado grueso y morteros usados en materiales de obras civiles, a partir de residuos solidos urbanos y residuos solidos industriales asimilables a urbanos.
Inventor: DURE JUAN CARLOS
IPC: B09B3/00
Filed: 2005-01-26
Abstract: Método de producción de agregado grueso y morteros usados en materiales de obras civiles, a partir de residuos sólidos urbanos y sólidos industriales asimilables a urbanos comprendiendo: 1) separación y clasificación de dichos residuos en material orgánico e inorgánico; 2) trituración del material inorgánico en una trituradora de inorgánicos; 3) trituración y mezcla con inertizante y agua del material orgánico, en trituradora de orgánicos; 4) amasado de la mezcla anterior hasta un PH=12 y 40?C; 5) transporte de la pasta inertizada al contenedor, y reposo durante 4h a 8h; 6) mezclado y amasado de material inorgánico triturado, pasta inertizada, un compactante y agua; 7) descarga del mortero.
Patent UY-30338-A1 (UY)
Title: Acidos carboxilicos sustituidos con fenilaminobenzoxazol, procedimientos para su preparacion y su uso como productos farmacéuticos.
Inventor: BARTOSCHEK DR STEFAN
IPC: A61K31/423
Filed: 2007-05-10
Abstract: Acidos carboxílicos sustituidos con fenilaminobenzoxazol, procedimientos para su preparacion y su uso como productos farmacéuticos La invencion se refiere a ácidos carboxílicos sustituidos con fenilaminobenzoxazol y a sus sales fisiologicamente toleradas. La invencion se refiere a compuestos de la formula I en la que R1, R2, R6, R7, R8, R9, R10, m y X tienen los significados establecidos, y a sus sales fisiologicamente toleradas. Los compuestos son adecuados para el tratamiento de la diabetes.
Patent UY-31033-A1 (UY)
Title: Utilizacion de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-oxido-piridin-4-il)-5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos de la medula espinal
Inventor: JOCELYNE LOLIVIER
IPC: C07D213/89
Filed: 2008-04-18
Abstract: L ainvencion se refiere a la utilizacion de 4-ciclopropilmetoxi-N-(3,5-dicloro-1-oxido-piridin-4-il)-5-(metoxi)piridin-2-carboxamida para la preparacion de un medicamento destinado al tratamiento de los traumatismos de médula espinal.
Patent ZW-12385-A1 (ZW)
Title: &-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3h)-yl)-benzeneacetonitriles
Inventor: GUSTAAF BOECKX
IPC: C07D243/06
Filed: 1985-07-30
Abstract: Novel  alpha -aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetontr iles which are effective in destruting and/or preventing the growth of Protozoa; pharmaceutical compositions comprising such compounds as active ingredients and processes of preparing such compounds and pharmaceutical compositions.
Patent ES-179787-A1 (ES)
Title: PERFECCIONAMIENTOS EN LOS DISPOSITIVOS DE INYECCIoN DE COMBUSTIBLE PARA MOTORES DE ACEITE PESADO
Filed: 1947-09-17
Abstract: Perfeccionamientos en el equipo de inyección de combustible para los motores de combustión interna, que incluyen una bomba de inyección que comprende un cuerpo inyector; un pistón de movimiento alternativo que trabaja en un cilindro del cuerpo para suministrar combustible, intermitentemente, a una tobera dispuesta en un extremo de la bomba de inyección; un émbolo para el gas, cargado por un muelle, preparado para trabajar en una cámara del cuerpo, sometido al control de un medio a presión suministrado a la cámara; el émbolo para el gas y el pistón citados están unidos de modo eficiente para que se muevan en forma de conjunto; y medios para proporcionar un tope de amortiguación para detener el pistón y el émbolo para el gas al final de una carrera.
Patent ES-180487-A1 (ES)
Title: Perfeccionamientos introducidos en los cilindros principales de los frenos hidraulicos de vehiculos automoviles
Filed: 1947-11-14
Abstract: Perfeccionamientos introducidos en los cilindros principales de los frenos hidráulicos de vehículos automóviles caracterizados por el hecho de comprender el cilindro dos émbolos móviles en direcciones opuestas y que actúan sobre circuitos hidráulicos separados para los frenos delanteros y los frenos traseros del vehículo.
Patent ES-193632-A1 (ES)
Title: UN PROCEDIMIENTO PARA OBTENER UNA CORRIENTE DE TENSIoN CONSTANTE EN EL SECUNDARIO DE UN CIRCUITO ELECTROMAGNÉTICO, CON INDEPENDENCIA DE LAS CARACTERiSTICAS DE LA CORRIENTE DEL PRIMARIO EN EL MISMO CIRCUITO
Filed: 1950-06-26
Abstract: Un procedimiento para obtener una corriente de tensión constante en el secundario de un circuito electromagnético. Con independencia de las características de la corriente del primario en el mismo circuito que se caracteriza porque utiliza la variación de reluctancia de un circuito magnético derivado de campo variable por la inclusión de un entrehierro en la armadura de derivación.
Patent ES-198178-A1 (ES)
Title: Un procedimiento y aparato para producir aglomerados endurecidos de mineral de hierro
Filed: 1951-06-04
Abstract: Procedimiento de producir aglomerados endurecidos al calor de mineral de hierro finamente dividido a temperaturas por debajo da temperatura de concreción que comprende mezclar al mineral menos de 2% da paso de carbono fijo; moldear la mezcla en píldoras verdes; cargar la capa de estas píldoras verdes sobre un soporte movible permeable a los gases; secar las píldoras verdes; precalentar y encender las píldoras secas con una llama para crear una zona caliente con una temperatura de 982 - 1285ºC y subsiguientemente mover dicha zona caliente progresivamente a través de toda la capa con ráfaga da aire sólo para endurecer dichas píldoras.
Patent ES-201609-A1 (ES)
Title: Improvements in ferritic alloy steels
IPC: C22C38/54
Filed: 1952-01-26
Abstract: A ferritic alloy steel has the following composition:-C 0.03-0.2 per cent., Si 0.1-1.5 per cent., Mn 0.1-2.0 per cent., Cr 3.5-8.0 per cent., Ti 0.05-0.4 per cent., V 0.01-0.5 per cent., B 0.001-0.05 per cent., W 0.4-2.5 per cent. and/or Mo 0.3-1.5 per cent., the maximum total content of W and Mo when both are present being 3.0 per cent., Fe, and incidental impurities, the remainder. The alloy may also contain Ni up to 2.0 per cent. The Provisional Specification describes also an alloy from which B is absent and in which the range of proportions C, Cr, Ti and W are C 0.03-0.25 per cent., Cr 3.5-9.0 per cent., Ti 0.05-0.5 per cent., W 0.5-2.5 per cent., the ranges of proportions of the other constituents being as stated above.